{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiftyd3m55x7xx4mbine7siuno62ugm2qx6nz7nkqqw4ibpmq4h4uy",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mgmwuahkpa62"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihs4yniv5gslv4xxwpwazmdqvpsj3sble4olz6hvbzdguafle3ihy"
    },
    "mimeType": "image/jpeg",
    "size": 123080
  },
  "path": "/pharmalot/2026/03/09/fda-biosimilars-prasad-novo-hims-weight-wegovy/?utm_campaign=rss",
  "publishedAt": "2026-03-09T13:11:56.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "Pharmalot",
    "pharmalittle",
    "STAT+"
  ],
  "textContent": "There is growing concern that the FDA is shunning advisory committees that allow agency leaders, drugmakers, patients, and doctors to speak their minds in public",
  "title": "STAT+: Pharmalot: We’re reading about a lack of FDA adcomms, FDA loosening biosimilar rules, and more",
  "updatedAt": "2026-03-09T13:12:00.000Z"
}